S&P 500   3,221.96 (+0.76%)
DOW   26,808.05 (+0.62%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,221.96 (+0.76%)
DOW   26,808.05 (+0.62%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,221.96 (+0.76%)
DOW   26,808.05 (+0.62%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,221.96 (+0.76%)
DOW   26,808.05 (+0.62%)
QQQ   260.47 (+0.03%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
Log in

CVE:RLVRelevium Technologies Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
C$0.03
MA: C$0.04
C$0.05
52-Week Range N/A
Volume691,901 shs
Average Volume948,031 shs
Market CapitalizationC$6.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Relevium Technologies Inc. engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and nutri cosmeceuticals primarily through its Bioganix brand portfolio online, as well as dietary supplements under the LeefyLyfe brand name through its wholesale, retail, and online distribution channels. It is also involved in the extraction, formulation, development, and encapsulation of proprietary nutraceutical products for medical purposes. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. The company was incorporated in 2012 and is headquartered in Montreal, Canada. Relevium Technologies Inc. is a subsidiary of iTech Medical, Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-514-8248559

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$4.20 million
Book ValueC$0.03 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$6.96 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RLV News and Ratings via Email

Sign-up to receive the latest news and ratings for RLV and its competitors with MarketBeat's FREE daily newsletter.

Relevium Technologies (CVE:RLV) Frequently Asked Questions

Has Relevium Technologies been receiving favorable news coverage?

Press coverage about RLV stock has been trending extremely negative this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Relevium Technologies earned a daily sentiment score of -4.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the company's share price in the next few days. View the latest news about Relevium Technologies.

Who are some of Relevium Technologies' key competitors?

What other stocks do shareholders of Relevium Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Canopy Growth (CGC), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), 1933 Industries (TGIF), Acquired Sales (AQSP), Aphria (APHA), Aphria (APHA) and Aldeyra Therapeutics (ALDX).

Who are Relevium Technologies' key executives?

Relevium Technologies' management team includes the following people:
  • Mr. Aurelio Useche C.M.A., M.B.A., Pres, CEO & Director (Age 51)
  • Mr. Edward Ierfino, Mang. of Investor Relations (Age 51)
  • Mr. Wayne D. Cockburn, Consultant (Age 62)
  • Mr. Faycal Salek, Chief Financial Officer
  • Mr. Abis Hussain, Sr. Marketing Officer

What is Relevium Technologies' stock symbol?

Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."

How do I buy shares of Relevium Technologies?

Shares of RLV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Relevium Technologies?

Relevium Technologies has a market capitalization of C$0.00 and generates C$4.20 million in revenue each year.

What is Relevium Technologies' official website?

The official website for Relevium Technologies is www.releviumcorp.com.

How can I contact Relevium Technologies?

Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.